Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Oct 1;176(10):1-3.
doi: 10.1001/jamainternmed.2016.1523.

Glucagon-like Peptide 1 Drugs as Second-line Therapy for Type 2 Diabetes

Peter C Butler  1
Affiliations
Editorial

Glucagon-like Peptide 1 Drugs as Second-line Therapy for Type 2 Diabetes

Peter C Butler. JAMA Intern Med. .

Erratum in

  • Missing Reference Citation.
    [No authors listed] [No authors listed] JAMA Intern Med. 2016 Oct 1;176(10):1579. doi: 10.1001/jamainternmed.2016.5900. JAMA Intern Med. 2016. PMID: 27695829 No abstract available.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Dr Butler is a member of the scientific advisory board for Semma Therapeutics. No other disclosures are reported.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Currie CJ, Johnson JA. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern. Diabetes Obes Metab. 2012;14(1):1–4. - PubMed
    1. Garg T, Rosas U, Rivas H, Azagury D, Morton JM. National prevalence, causes, and risk factors for bariatric surgery readmissions. Am J Surg. 2016;212(1):76–80. - PubMed
    1. Vanderheiden A, Harrison L, Warshauer J, Li X, Adams-Huet B, Lingvay I. Adding liraglutide to a high-dose insulin regimen: a randomized, double-blind, placebo-control study [published online June 6, 2016] JAMA Intern Med - PubMed
    1. Azoulay L, Filion KB, Platt RW, et al. Association between incretin-based drugs and the risk of acute pancreatitis [published online August 1, 2016] JAMA Intern Med - PubMed
    1. Azoulay L, Filion KB, Platt RW, et al. Canadian Network for Observational Drug Effect Studies Investigators. Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study. BMJ. 2016;352:i581. - PMC - PubMed